Academic · Private company

RTOG Foundation, Inc.

Track this companyFree. Adds RTOG Foundation, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials43 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior TreatmentPHASE2 · RECRUITING · started Aug 24, 2025ClinicalTrials.gov NCT06955169 · fetched Nov 12, 2026
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following SurgeryPHASE2 · ACTIVE_NOT_RECRUITING · started Apr 15, 2019ClinicalTrials.gov NCT03809000 · fetched Nov 12, 2026
SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck CarcinomaPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 14, 2018ClinicalTrials.gov NCT03546582 · fetched Nov 12, 2026
Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck CancerPHASE1 · COMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT02764593 · fetched Nov 12, 2026